Some people, especially those with severe soy allergies, may need to avoid soy lecithin
39 An additional therapy that has been studied for use in HFpEF is the interatrial shunting device (IASD), which aims to relieve left atrial pressure through the artificial creation of connection between atria (or in some approaches between the left atrium and coronary sinus)
Popular across 2025 GLP-1 rankings, Delilah's system is praised for its telehealth simplicity, stimulant-free design, and seamless integration with popular health tech tools like Fitbit, WHOOP, and Oura Ring
Ozempic/Wegovy (semaglutide) , Novo Nordisks GLP-1 receptor agonist, has patent protection running through the early 2030s in most markets, though the precise timeline is subject to ongoing litigation from generic and biosimilar challengers who are already preparing entry strategies [39]